Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma

Glioblastoma (GBM) is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The mechanisms of radioresistance are not completely understood. However, cancer cells with an immature stem-like phenotype are hypothesised to play a role in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Svendsen, Agnete, Verhoeff, Joost J. C., Immervoll, Heike, Brøgger, Jan C., Kmiecik, Justyna, Poli, Aurelie, Netland, Inger A., Prestegarden, Lars, Planagumà, Jesús, Torsvik, Anja, Kjersem, Anneli Bohne, Sakariassen, Per Ø., Heggdal, Jan I., Van Furth, Wouter R., Bjerkvig, Rolf, Lund-Johansen, Morten, Enger, Per Ø., Felsberg, Joerg, Brons, Nicolaas H. C., Tronstad, Karl J., Waha, Andreas, Chekenya, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185228/
https://www.ncbi.nlm.nih.gov/pubmed/21863242
http://dx.doi.org/10.1007/s00401-011-0867-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185228/
https://www.ncbi.nlm.nih.gov/pubmed/21863242
http://dx.doi.org/10.1007/s00401-011-0867-2

Ejemplares similares